Publications
1. Bone Marrow Transplantation in 14 children with severe sickle cell disease: the French experience. Bernaudin F, Souillet F, Vannier JP et al. F or the SFGM. Bone Marrow Transpl. 1993; 12, S 1 : 118-21.
2. Detection of cerebrovascular disease in sickle cell disease children by transcranial Doppler sonography. Correlation with MRI and MRA and conventionnal angiography. Verlhac S, Bernaudin F, Tortrat D et al. Pediatric Radiology 1995; 25: S14-S19.
3. Exploration de la vasculopathie cérébrale drépanocytaire. Verlhac S. Path Biol 1999 ; 47, 1 : 31-8.
4. Multicenter prospective study of children with sickle cell disease: radiographic and psychometric correlation. Bernaudin F, Verlhac S, Fréard F, Roudot-Thoraval F, Benkerrou M, Thuret I, et al. J Child Neurol 2000;15(5):333-43
5. Early cerebral exploration with transcranial Doppler in patients with sickle cell disease : effects of age and risk factors on velocities. Bernaudin F, Verlhac S, Lesprit E et al. Blood 2001
6. Children with sickle cell disease : remaining high velocities by transcranial Doppler under transfusion program are related to stenoses. Verlhac S, Bernaudin F, Lesprit E, Brugières P, Mage K. Pediatr Radiol 2001; 31 : S29
7. Echodoppler transcrânienne chez les enfants drépanocytaires. Suzanne Verlhac, Françoise Bernaudin. Hématologie, n°hors-série, 8, 3/2002, abstract 53 p32
8. Clinique et génétique de la Drépanocytose. F. Bernaudin. Concours Médical, 2003, 125-08 : 476-482 (Cliquez)
9. Doppler transcrânien chez l’enfant drépanocytaire. VERLHAC S, BERNAUDIN F et BRUGIERES P.J Radiol 2003 (Cliquez) ;84 :131-8
10. Greffe Et Drépanocytose. F Bernaudin in livre : La Drépanocytose John Libbey Eurotext 2003 Pages 267-273
11. Complications Neurologiques De La Drépanocytose. P Beauvais, S Verlhac, F Bernaudin. Livre : La Drépanocytose John Libbey Eurotext 2003 Pages 145-160
12. Perspectives thérapeutiques, cliniques et psychologiques dans les formes sévères de Drépanocytose. F Bernaudin, J Pradère, O Taiëb, T Abbal, M Champion, B Dutray, D N’Gaba, L Coïc, D Bonnet, MR Moro. Livre : La Drépanocytose Regards croisés sur une maladie orpheline Sous la direction d’Agnès Lainé aux Editions Karthala ; 2004 : 293-306
13. Indications et résultats de la greffe. F Bernaudin. Revue du Praticien 2004, 54, 14, 1565-1567
14. Long term follow-up of pediatric sickle cell disease patients with abnormal high velocities on transcranial Doppler (Cliquez), F Bernaudin, S Verlhac, L Coïc, E Lesprit, P Brugières, P Reinert Pediatric Radiol 2005, 35, 3 : 242-248
15. Evolution à long terme des patients drépanocytaires pédiatriques avec vitesses anormalement élevées au doppler transcrânien. F Bernaudin, S Verlhac, L Coic, E Lesprit, P Brugières, P Reinert, Hématologie 2005, abstract 03-30 p 33
16. Suivi prospectif de la cohorte des Syndromes drépanocytaires Majeurs dépistés en néonatal à Créteil. F Bernaudin, E Lesprit, I Abadie, L Coïc, S Verlhac, J Barddakdian-Michau, F Galactéros, P Reinert. Hématologie 2005, abstract 03-31 p 34
17. Suivi d’une cohorte de 225 enfants drépanocytaires sous hydroxyurée. M de Montalembert, V Brousse, C Elie, F Bernaudin, J Shi, P Landais, Hématologie 2005, abstract 03-05 p 22
18. Long term follow-up of pediatric sickle cell disease patients with conditional velocities on transcranial doppler. L Coic, S Verlhac, E Lesprit, E Fleurence, F Bernaudin Blood 2005 ; 106, 11, abstract
19. Long term prospective follow-up after treatment intensification in pediatric sickle cell patients : comparative effects of transfusion program, hydroxyurea or stem cell transplant on annual check-ups . F Bernaudin, E Lesprit, L Coic, C Arnaud, E Fleurence, S Verlhac, C Delacourt, Blood 2005 ; 106, 11, abstract 3196, 893a
20. Comparative effects of transfusion program, hydroxyurea or stem cell transplant on frequency of hospitalisations in pediatric sickle cell patients . C Arnaud, A Kamdem, L Coic, E Lesprit, E Fleurence, F Mahdi, S Lemerle, C Delacourt, F Bernaudin .Blood 2005 ; 106, 11, abstract 318, 97a
21. A Randomized, Controlled Phase II Trial in Sickle Cell Disease Patients with Chronic Iron Overload Demonstrates that the Once-Daily Oral Iron Chelator Deferasirox (ICL670, EXJADE®) is Well-Tolerated and Reduces Iron Burden Eliot Vichinsky, Roland Fischer, Ellen Fung, Thomas Coates,Peter Lane, Beatrice Files*, Brigitta U. Mueller, Françoise Bernaudin, Gianluca Forni, Oninye Onyekwere, John Porter, Paul Swerdlow, Catherine Ressayre-Djaffer, Insa Gathmann*, Jaymes Holland*, Daniele Alberti*, Peter Marks. Blood 2005 ; 106, 11, abstract 313, 95a
22. Long-term hydroxyurea treatment in children with sickle cell disease : tolerance and clinical outcomes. M de Montalembert, V Brousse, C Elie, F Bernaudin, J Shi, P Landais Haematologica 2006 ; 91 : 125-128
23. Deferasirox in Sickle Cell Investigators. A randomised comparison of deferasirox versus deferoxamine for the treatment of transfusional iron overload in sickle cell disease. Vichinsky E, Onyekwere O, Porter J, Swerdlow P, Eckman J, Lane P, Files B, Hassell K, Kelly P, Wilson F, Bernaudin F, Forni GL, Okpala I, Ressayre-Djaffer C, Alberti D, Holland J, Marks P, Fung E, Fischer R, Mueller BU, Coates T . Br J Haematol. 2007 Feb;136(3):501-8.
24. Primary Epstein-Barr virus infection with pneumonia transmitted by allogeneic bone marrow after transplantation. Teira P, Agbalika F, Bergeron A, Bernaudin F, Carmagnat M, Peffault de Latour R, Rocha V, Devergie A, Rabian C, Gluckman E, Ribaud P, Socie G, Robin M. Clin Infect Dis. 2006 Oct 1;43(7):892-5
25. Haematopoietic stem cell transplantation in patients with sickle cell disease. E Gluckman, F Bernaudin. ESH The Handbook 2006 Edition forum service editore Chapter 14..2 324-332
26. Crises drépanocytaires. M Chaïbou, G Chéron, M Benkerrou, F Bernaudin. Livre « Urgences et Soins Intensifs Pédiatriques » . Lacroix J, Gauthier M, Hubert P, Leclerc F, Gaudreault P . Éditions du CHU Sainte-Justine et Elsevier-Masson, 2007 : 547-560
27. Efficacité de l’exploration précoce par Doppler transcrânien dans la prévention des accidents vasculaires cérébraux : expérience monocentrique d’une cohorte d’enfants drépanocytaires dépistés en néonatal. F Bernaudin, S verlhac, L Coïc, E lesprit, C Arnaud, A Kamdem, I Abadie, J Bardakdjian, F Galactéros, P Reinert, C Delacourt. Hématologie, 2007 : n° spécial 2, vol 13 abstract 03-27 p 29
28. I Thuret, C Badens, C Pondarre, C Rose, B Pegourié, J troncy, P Rorlich, P Lutz, M Micheau, F Bernaudin, C Berger, D Lena-Russo centre de Référence des Thalassémies. Hématologie, 2007 : n° spécial 2, vol 13 abstract 03-31 p 31
29. Cerebral vasculopathy outcome after stem cell transplantation for sickle cell disease. Bone Marrow Transplant. F Bernaudin, S Verlhac, G Socié, M Kuentz, M Duval, Y Bertrand, JP Vannier, K Yakouben, I Thuret, P Bordigoni, A Fischer, P Lutz, N Dhedin, JP Vernant, E Gluckman on behalf of the SFGM-TC. 2007, 39 S1, abstract 0308 p S35
30. Long-Term results of Related Myeloablative Stem Cell Transplantation to Cure Sickle Cell Disease. F Bernaudin, G Socié, M Kuentz, S Chevret, M Duval, Y Bertrand, JP Vannier, K Yakouben, I Thuret, P Bordigoni, A Fischer, P Lutz, JL Stéphan, N Dhedin, E Plouvier, G Margueritte, D Bories, S Verlhac, H Espérou, L Coïc, JP Vernant, E Gluckman for the SFGM-TC. Blood, 2007 ;110 :2749-2756
31. Place du Doppler transcrânien et de l'imagerie en résonance magnétique dans la drépanocytose. S Verlhac, F Bernaudin. Médecine thérapeutique Pédiatrie, 2008, vol 11, n°1, 55-66
32. Intensifications de traitement chez l'enfant drépanocytaire . F Bernaudin. Médecine thérapeutique Pédiatrie, 2008, vol 11, n°1, p67-73
33. Les chambres implantables. C Arnaud, L Coïc, P Beriel, E Leveille, F Yim, F Bernaudin. Médecine thérapeutique Pédiatrie, 2008, vol 11, n°1, p74-78
34. Enjeux psychiques de la guérison dans la drépanocytose après allogreffe de cellules souches hématopoïétiques. É Drain, O Taïeb, J Pradère, F Bernaudin, M-R Moro. Médecine thérapeutique Pédiatrie, 2008, vol 11, n°1, p84-89
35. [Stem cell transplantation in sickle cell disease: results, perspectives]F Bernaudin; Arch Pediatr . 2008 Jun; 15 ( 5 ): 633-5
36. G6PD deficiency, absence of alpha-thalassemia and hemolytic rate at baseline are significant independent risk factors for abnormally high cerebral velocities in patients with sickle cell anemia. Bernaudin F, Verlhac S, Chevret S, Torres M, Coic L, Arnaud C, Kamdem A, Hau I, Neonato MG, Delacourt C. Blood . 2008 Sep 4
37. Transcranial Doppler and prevention of stroke in sickle cell disease. S Verlhac. Arch Pediatr . 2008 Jun; 15 ( 5 ): 636-8
38. Increased cerebral blood flow velocity in children with sickle cell disease: adenotonsillectomy or transfusion regimens? Bader-Meunier B, François M, Verlhac S, Elmaleh M, Ithier G, Benkerrou M. Pediatrics . 2007 Jul; 120 ( 1 ): 235-6
39. Bernaudin F, Verlhac S. La prévention des accidents vasculaires cérébraux chez les malades drépanocytaires. Résultats, problèmes et avenir. Bull. Acad. Natle Méd., 2008, 192, n°7, 1383-1394, séance du 28 octobre 2008
40. Effect of transfusion therapy on cerebral vasculopathy in children with sickle-cell anemia. Haematologica. Bader-Meunier B, Verlhac S, Elmaleh-Bergès M, et al.2009 January; 94(1): 123–126
41. Rédaction de la fiche : Echographie Doppler Couleur transcrânienne (EDTC) pour le site web d’aide à la décision médicale des professionnels de la santé. Verlhac S. 2009. http://www.admp.fr
42. Feasibility and efficacy of chronic transfusion for stroke prevention in children with sickle cell disease. Mirre E, Brousse V, Berteloot L, Lambot-Juhan K, Verlhac S, Boulat C, Dumont MD, Lenoir G, de Montalembert ; Eur J Haematol. 2010 Mar;84(3):259-65. Epub 2009 Nov
43. Echodoppler transcrânien et drépanocytose. Verlhac S, Balandra S. Angiologie, 2010, 62 ;1 :65-68
44. Impact of early transcranial Doppler screening and intensive therapy on cerebral vasculopathy outcome in a newborn sickle cell anemia cohort. Bernaudin F,, Verlhac S, Arnaud C, et al. Blood, 2011 , 117,4 , epub 2010 nov
45. Transcranial Doppler in children. Verlhac S.Pediatr Radiol 2011, 41 (Suppl 1):S153–S165
46. Impact of early transcranial Doppler screening and intensive therapy on cerebral vasculopathy outcome in a newborn sickle cell anemia cohort. Bernaudin F, Verlhac S, Arnaud C, Kamdem A, Chevret S, Hau I, Coïc L, Leveillé E, Lemarchand E, Lesprit E, Abadie I, Medejel N, Madhi F, Lemerle S, Biscardi S, Bardakdjian J, Galactéros F, Torres M, Kuentz M, Ferry C, Socié G, Reinert P, Delacourt C. Blood. 2011 Jan 27;117(4):1130-40; quiz 1436. doi: 10.1182/blood-2010-06-293514. Epub 2010 Nov 10.
47. Advances in understanding the pathogenesis of cerebrovascular vasculopathy in sickle cell anaemia. Connes P, Verlhac S, Bernaudin F. Br J Haematol. 2013 May;161(4):484-98. doi: 10.1111/bjh.12300. Epub 2013 Mar 18. Review.
48. Iron overload of hematological origin: Validation of a screening procedure for cardiac overload by MRI in routine clinical practice. Ernst O, Thuret I, Petit P, Ameurd F, Loundoue AD, de Kerviler E, Izzilog R, Willig AL, Pascal L, Verlhac S, Mordon S, Fenaux P, Rose C; Diagnostic and interventional Imaging. 2013. 94, 601-608
49. Liver iron overload assessment by MRI R2* relaxometry in highly transfused pediatric patients: An agreement and reproducibility study. Verlhac S, Morel M, Bernaudin F, Béchet S, Jung C, Vasile M; Diagnostic and Interventional Imaging, 2014, 96, 3:259-264
50. Extracranial carotid arteriopathy in stroke-free children with sickle cell anemia: detection by submandibular Doppler sonography. Verlhac S, Balandra S, Cussenot I, Kasbi F, Vasile M, Kheniche A, Elmaleh-Bergès M, Ithier G, Benkerrou M, Bernaudin F, Sebag G. Pediatr Radiol. 2014 May;44(5):587-96. doi: 10.1007/s00247-014-2880-9. Epub 2014 Mar 6.
51. Hematopoietic stem cell transplantation in thalassemia major and sickle cell disease: indications and management recommendations from an international expert panel. Angelucci E, Matthes-Martin S, Baronciani D, Bernaudin F, Bonanomi S, Cappellini MD, Dalle JH, Di Bartolomeo P, de Heredia CD, Dickerhoff R, Giardini C, Gluckman E, Hussein AA, Kamani N, Minkov M, Locatelli F, Rocha V, Sedlacek P, Smiers F, Thuret I, Yaniv I, Cavazzana M, Peters C; EBMT Inborn Error and EBMT Paediatric Working Parties. Haematologica. 2014 May;99(5):811-20. doi: 10.3324/haematol.2013.099747.
52. Chronic and acute anemia and extracranial internal carotid stenosis are risk factors for silent cerebral infarcts in sickle cell anemia. Bernaudin F, Verlhac S, Arnaud C, Kamdem A, Vasile M, Kasbi F, Hau I, Madhi F, Fourmaux C, Biscardi S, Epaud R, Pondarré C. Blood. 2015 Mar 5;125(10):1653-61. doi: 10.1182/blood-2014-09-599852. Epub 2014 Dec 22.
53. Use of Transcranial Doppler Ultrasonography in the Pediatric Intensive Care Unit-Consultant Level Examination. Suzanne Verlhac, Charlotte Michot. Chapitre du livre Critical care ultrasound. Elsevier Saunders, 2015
54. First Ischemic Stroke in Sickle-Cell Disease: Are There Any Adult Specificities? Calvet D, Bernaudin F, Gueguen A, Hosseini H, Habibi A, Galactéros F, Bartolucci P. Stroke. 2015 Aug;46(8):2315-7. doi: 10.1161/STROKEAHA.115.010153. Epub 2015 Jul 14.
55. Comparison of automated erythrocytapheresis versus manual exchange transfusion to treat cerebral macrovasculopathy in sickle cell anemia. Koehl B, Sommet J, Holvoet L, Abdoul H, Boizeau P, Ithier G, Missud F, Couque N, Verlhac S, Voultoury P, Sellami F, Baruchel A, Benkerrou M. Transfusion. 2016 May;56(5):1121-8. Epub 2016 Mar 28.
56. Long-term treatment follow-up of children with sickle cell disease monitored with abnormal transcranial Doppler velocities. Bernaudin F, Verlhac S, Arnaud C, Kamdem A, Hau I, Leveillé E, Vasile M, Kasbi F, Madhi F, Fourmaux C, Biscardi S, Gluckman E, Socié G, Dalle JH, Epaud R, Pondarré C. Blood. 2016 Apr 7;127(14):1814-22. /blood-2015-10-675231. Epub 2016 Feb 5.
57. Clinical and haematological risk factors for cerebral macrovasculopathy in a sickle cell disease newborn cohort: a prospective study. Sommet J, Alberti C, Couque N, Verlhac S, Haouari Z, Mohamed D, François M, Missud F, Holvoet L, Elmaleh M, Ithier G, Denjean A, Elion J, Baruchel A, Benkerrou M. Br J Haematol. 2016 Mar;172(6):966-77. doi: 10.1111/bjh.13916. Epub 2016 Jan 5.
58. Treating sickle cell anaemia: the TWiTCH trial. Bernaudin F, Verlhac S, Chevret S. Lancet. 2016 Sept; 388 (960).
59. Allogeneic/Matched Related Transplantation for β-Thalassemia and Sickle Cell Anemia. Bernaudin F, Pondarré C, Galambrun C, Thuret I. Adv Exp Med Biol. 2017;1013:89-122. doi: 10.1007/978-1-4939-7299-9_4.
60. Design of the DREPAGREFFE trial: A prospective controlled multicenter study evaluating the benefit of genoidentical hematopoietic stem cell transplantation over chronic transfusion in sickle cell anemia children detected to be at risk of stroke by transcranial Doppler (NCT 01340404). Chevret S, Verlhac S, Ducros-Miralles E, Dalle JH, de Latour RP, de Montalembert M, Benkerrou M, Pondarré C, Thuret I, Guitton C, Lesprit E, Etienne-Julan M, Elana G, Vannier JP, Lutz P, Neven B, Galambrun C, Paillard C, Runel C, Jubert C, Arnaud C, Kamdem A, Brousse V, Missud F, Petras M, Doumdo-Divialle L, Berger C, Fréard F, Taieb O, Drain E, Elmaleh M, Vasile M, Khelif Y, Bernaudin M, Chadebech P, Pirenne F, Socié G, Bernaudin F. Contemp Clin Trials. 2017 Nov;62:91-104. doi: 10.1016/j.cct.2017.08.008. Epub 2017 Aug 15.
61. Is transplantation an alternative to the transfusional impasse in sickle cell disease?] Bernaudin F, Kuentz M. Transfus Clin Biol. 2017 Sep;24(3):232-236. doi: 10.1016/j.tracli.2017.06.007. Epub 2017 Jun 23. French.
62. Family cord blood banking for sickle cell disease: a twenty-year experience in two dedicated public cord blood banks. Rafii H, Bernaudin F, Rouard H, Vanneaux V, Ruggeri A, Cavazzana M, Gauthereau V, Stanislas A, Benkerrou M, De Montalembert M, Ferry C, Girot R, Arnaud C, Kamdem A, Gour J, Touboul C, Cras A, Kuentz M, Rieux C, Volt F, Cappelli B, Maio KT, Paviglianiti A, Kenzey C, Larghero J, Gluckman E. Haematologica. 2017 Jun;102(6):976-983. doi: 10.3324/haematol.2016.163055. Epub 2017 Mar 16.
63. Greffe dans la drépanocytose : résultats, indications et perspectives. Bernaudin F, Dhedin N, pour la SFGM-TC. Hematologie 2016 ; 22 : 117-134. doi :10.1684/hma.2016.1120
64. Sickle cell disease: an international survey of results of HLA-identical sibling hematopoietic stem cell transplantation. Gluckman E, Cappelli B, Bernaudin F, Labopin M, Volt F, Carreras J, Pinto Simões B, Ferster A, Dupont S, de la Fuente J, Dalle JH, Zecca M, Walters MC, Krishnamurti L, Bhatia M, Leung K, Yanik G, Kurtzberg J, Dhedin N, Kuentz M, Michel G, Apperley J, Lutz P, Neven B, Bertrand Y, Vannier JP, Ayas M, Cavazzana M, Matthes-Martin S, Rocha V, Elayoubi H, Kenzey C, Bader P, Locatelli F, Ruggeri A, Eapen M; Eurocord, the Pediatric Working Party of the European Society for Blood and Marrow Transplantation, and the Center for International Blood and Marrow Transplant Research. Blood. 2017 Mar 16;129(11):1548-1556. doi: 10.1182/blood-2016-10-745711. Epub 2016 Dec 13.
---------